FDA Adverse Event Other Summary report: N

COAPTITE INJECTABLE IMPLANT

MDR report key: 3429669 · Received October 17, 2013

Report

Report Number
2135225-2013-00114
Event Type
Other
Date Received
October 17, 2013
Date of Event
January 24, 2013
Report Date
September 20, 2013
Manufacturer
MERZ NORTH AMERICA, INC.
Product Code
LNM
PMA / PMN Number
P040047
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). ON (B)(6) 2013 THE UTI RESOLVED. PER THE PHYSICIAN, THE EVENT WAS OF MODERATE SEVERITY AND DEFINITELY NOT RELATED TO COAPTITE. THE DEVICE HISTORY RECORD FOR THE REPORTED LOT WAS REVIEWED. ALL REQUIRED TESTING SPECIFICATIONS WERE MET PRIOR TO RELEASE. THERE WERE NO ABNORMALITIES.

Description of Event or Problem · 1

A PT ((B)(6)) WAS ENROLLED IN THE POST-APPROVAL STUDY FOR STRESS URINARY INCONTINENCE. ON (B)(6) 2012 THE PT WAS INJECTED WITH 2.0 ML OF COAPTITE, LOT 1031985. ON (B)(6) 2013 THE PT REPORTED A URINARY TRACT INFECTION (UTI). ON (B)(6) 2013 THE PT WAS PRESCRIBED MACRODANTIN 100 MG # 10.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
533604 COAPTITE INJECTABLE IMPLANT INJECTABLE IMPLANT LNM MERZ NORTH AMERICA, INC. 1031985

Patients

Seq Age Sex Outcome Treatment
1 57 YR Required Intervention